CSIMarket
 


Inhibitor Therapeutics Inc   (HPPI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Inhibitor Therapeutics Inc 's Working Capital Ratio

HPPI's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




HPPI Working Capital Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Current Liabilities Change 6.5 % -38.48 % -34.64 % -34.01 % -26.38 %
Y / Y Current Assets Change -70.18 % -26.41 % -18.33 % 89.84 % -37.22 %
Working Capital Ratio MRQ 1.01 1.96 3.96 6.77 3.62
Overall Ranking # # # # #
Seq. Current Liabilities Change -19.76 % 20.12 % 17.75 % -6.16 % -53.65 %
Seq. Current Assets Change -58.53 % -40.52 % -31.04 % 75.31 % 2.34 %



Working Capital Ratio first quarter 2020 Comment
Despite sequential decrease in Current Liabilities, Working Capital Ratio detoriated to 1.01 below company average Working Capital Ratio.

Within Biotechnology & Drugs industry 70 other companies have achieved higher Working Capital Ratio than Inhibitor Therapeutics Inc in first quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is HPPI most successful ?
Working Capital Ratio HPPI on the trailing twelve month basis
Working Capital Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 71
Healthcare Sector # 329
Overall Market # 1674


Working Capital Ratio Statistics
High Average Low
23.36 3.66 0.01
(Dec 31 2016)   (Mar 31 2014)




Financial Statements
Inhibitor Therapeutics Inc 's Current Liabilities $ 0 Millions Visit HPPI's Balance sheet
Inhibitor Therapeutics Inc 's Current Assets $ 0 Millions Visit HPPI's Balance sheet
Source of HPPI's Sales Visit HPPI's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Working Capital RatioMar 31 2020 MRQ Current AssetsMar 31 2020 MRQ Current Liabilities
Curis Inc  2.76 $ 16.509  Millions$ 5.986  Millions
Cidara Therapeutics Inc   2.72 $ 80.621  Millions$ 29.629  Millions
Axovant Gene Therapies Ltd.  2.67 $ 85.430  Millions$ 32.043  Millions
Oncocyte Corp  2.62 $ 18.139  Millions$ 6.928  Millions
Windtree Therapeutics Inc  2.61 $ 18.098  Millions$ 6.939  Millions
Trovagene Inc   2.56 $ 10.283  Millions$ 4.011  Millions
Vermillion Inc   2.51 $ 9.986  Millions$ 3.985  Millions
Sellas Life Sciences Group Inc   2.50 $ 8.790  Millions$ 3.512  Millions
Acorda Therapeutics inc   2.38 $ 168.285  Millions$ 70.628  Millions
Cv Sciences Inc   2.33 $ 27.191  Millions$ 11.694  Millions
Regenerx Biopharmaceuticals Inc  2.32 $ 0.651  Millions$ 0.280  Millions
Cyanotech Corp  2.32 $ 14.728  Millions$ 6.359  Millions
Oncternal Therapeutics Inc   2.30 $ 16.564  Millions$ 7.216  Millions
Acasti Pharma Inc   2.20 $ 16.079  Millions$ 7.319  Millions
Obalon Therapeutics Inc  2.17 $ 15.570  Millions$ 7.188  Millions
Aptevo Therapeutics Inc   2.12 $ 14.825  Millions$ 6.993  Millions
Quidel Corp  2.10 $ 286.479  Millions$ 136.196  Millions
Chromadex Corp   2.01 $ 29.147  Millions$ 14.466  Millions
Genocea Biosciences Inc   1.98 $ 29.071  Millions$ 14.665  Millions
Aytu Bioscience Inc  1.98 $ 83.255  Millions$ 42.033  Millions
Urovant Sciences Ltd   1.91 $ 58.318  Millions$ 30.580  Millions
Brainstorm Cell Therapeutics Inc   1.84 $ 15.205  Millions$ 8.252  Millions
Brickell Biotech Inc   1.82 $ 12.892  Millions$ 7.091  Millions
Ayala Pharmaceuticals Inc   1.77 $ 11.450  Millions$ 6.466  Millions
Biogen Inc   1.73 $ 8,007.200  Millions$ 4,638.600  Millions
Protokinetix Inc   1.69 $ 0.049  Millions$ 0.029  Millions
Amgen Inc   1.59 $ 18,813.000  Millions$ 11,827.000  Millions
Pulmatrix Inc   1.56 $ 26.247  Millions$ 16.848  Millions
Soligenix Inc   1.53 $ 9.569  Millions$ 6.241  Millions
Cerecor Inc   1.47 $ 25.485  Millions$ 17.330  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ZOSN's Profile

Stock Price

ZOSN's Financials

Business Description

Fundamentals

Charts & Quotes

ZOSN's News

Suppliers

ZOSN's Competitors

Customers & Markets

Economic Indicators

ZOSN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071